3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
7
Recurrence
1
Purpura
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Nausea
1
Macroglossia
1
Lymphoma
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Hepatomegaly
1
Hematologic Neoplasms
1
Gastrointestinal Hemorrhage
1
Diarrhea
1
Constipation
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dexamethasone
32
Cyclophosphamide
30
fludarabine phosphate
25
Melphalan
25
Busulfan
25
Bortezomib
21
Tacrolimus
20
Lenalidomide
19
Peripheral Blood Stem Cell Transplantation
18
Mycophenolic Acid
17
Whole-Body Irradiation
16
Antilymphocyte Serum
16
fludarabine
14
Calcium Dobesilate
13
Thalidomide
12
Filgrastim
12
Granulocyte Colony-Stimulating Factor
11
Methotrexate
10
pomalidomide
9
Cyclosporine
8
Radiotherapy
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
Surveys and Questionnaires
5
Stem Cell Transplantation
5
Rituximab
5
Methylprednisolone
5
sargramostim
4
carfilzomib
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Plasma Cell
×
isatuximab
×
Clear all
No trials found.